PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION, page-191

  1. 832 Posts.
    lightbulb Created with Sketch. 331
    Next IND Go / No Go Date is by Monday 8th Nov. I suspect we are now sitting in the FDA 30 day communication out pile
    Maybe the PAR Quarterly Update, which is due before then will shed some light on 008 and when the re-submission was made.
    So glad the FDA are worried about opioids enough to respond to PAR in a more timely manner so we can get this party started wink.png
    Time to blow up the shorts (or a least rip a hole in them).
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.